Initial and Long-Term Efficacy of a Lipid Emulsion of Amphotericin B Desoxycholate in the Management of Canine Leishmaniasis

Journal of Veterinary Internal Medicine

Volumn 17, Issue 6, 2003, Pages 808-812

  Cortadellas, Oscar ^a  

^a Clinica Veterinaria Germanias   (Spain)

Author keywords

Dog; Leishmania infantum; PCR; Soybean oil; Treatment

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE;

ANOREXIA; ARTICLE; BONE MARROW EXAMINATION; DOG; DRUG EFFICACY; EMULSION; FEMALE; LEISHMANIA; LEISHMANIASIS; MALE; NONHUMAN; VOMITING;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; DEOXYCHOLIC ACID; DNA, PROTOZOAN; DOG DISEASES; DOGS; DRUG COMBINATIONS; EMULSIONS; FEMALE; LEISHMANIA; LEISHMANIASIS; MALE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

CANIS FAMILIARIS; GLYCINE MAX; LEISHMANIA INFANTUM;

EID: 0346364979     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2003)017<0808:IALEOA>2.3.CO;2     Document Type: Article

References (40)

1. World Health Organization. Control of the leishmaniasis. Geneva: WHO; 1990:793. Technical Report Series.
2. Denerolle P, Bourdoiseau G. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J Vet Intern Med 1999; 13:413-415.
3. Ferrer L. Leishmaniasis. In: Kirk RW, ed. Current Veterinary Therapy XI. Philadelphia, PA: WB Saunders; 1992:266-270.
4. Alvar J, Molina R, San Andres M, et al. Canine leishmaniasis: Clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol 1994;88:371-378.
5. Anonymous. The leishmaniasis and leishmania/HIV co-infection. Inf Circ WHO Mediterr Zoon Control Cent 1997;40:11-13.
6. Font A. Canine leishmaniasis. Proceedings of the 17th ACVIM Forum, Chicago, IL, 1999:630-632.
7. Slappendel RJ. Canine leishmaniosis. Vet Q 1988;10:1-17.
8. Cavaliero T, Arnold P, Mathis A, et al. Clinical, serologic and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum. J Vet Intern Med 1999;13: 330-334.
9. Denerolle P. Leishmaniose canine: Difficultés du diagnostic et du traitement (125 cas). Prat Med Chir Anim Comp 1996;31:137-145.
10. Koutinas AF, Polizopoulu ZS, Saridomichaelis MN, et al. Clinical considerations on canine visceral leishmaniasis in Greece: A retrospective study of 158 cases (1989-1996). J Am Anim Hosp Assoc 1999;35:376-382.
11. Berrahal F, Mary C, Roze M, et al. Canine leishmaniasis: Identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am J Trop Med Hyg 1996:55:273-277.
12. Gramiccia M, Grandoni L, Orsini S. Decreased sensitivity to meglumine antimoniate (glucantime) of Leishmania infantum isolated from dogs after several course of drug treatment. Ann Trop Med Parasitol 1992;86:613-620.
13. Lester SJ, Kenyon JE. Use of allopurinol to treat visceral leishmaniosis in a dog. J Am Vet Med Assoc 1996;209:615-617.
14. Font A, Roura X, Fondevilla D, et al. Canine mucosal leishmaniasis. J Am Anim Hosp Assoc 1996;32:131-137.
15. Koutinas AF, Saridomochelakis MN, Mylonakis ME, et al. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniasis. Vet Parasitol 2001;98:247-261.
16. Ferrer L. Leishmaniasis: Update in diagnosis and therapy. Proceedings of the 14th Congress of the European Society of Veterinary Dermatology, Pisa, Italy, 1999.
17. Mishra M, Biswas UK, Jah A. Amphotericin versus sodium stibogluconate in first line treatment of Indian kala-azar. Lancet 1994; 344:1599-1600.
18. Laguna F, Lopez Velez R, Pulido F. Treatment of visceral leishmaniasis in HIV-infected patients: A randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group. AIDS 1999;9:1063-1069.
19. Maddux MS, Barriere SL. A review of complications of amphotericin B therapy: Recommendations for prevention and management. Drug Intell Clin Pharm 1980;14:177-181.
20. Lamothe J. Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniasis. J Small Anim Pract 2001;42: 170-175.
21. Chavanet P. Amphotericin B desoxycholate Fungizone®: Vieux médicament, nouvelles versions. Rev Med Interne 1997;18:153-165.
22. Brown SA, Henik RA, Finco DR. Diagnosis of systemic hypertension in dogs and cats. In: Kirk RW, ed. Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders; 2000:835-838.
23. Lamothe J. Treatment of canine leishmaniasis from A (amphotericin B) to Z (Zyloric). Proceedings of a Canine Leishmaniasis Forum, Barcelona (Sitges), January 1999:12-17 (Hoechst Roussel Vet).
24. Sherding RL, Johnson SE. Intestinal histoplasmosis. In: Kirk RW, ed. Current Veterinary Therapy XI. Philadelphia, PA: WB Saunders; 1992:266-270.
25. Roura X, Sanchez A, Ferrer L. Diagnosis of canine leishmaniasis by a polymerase chain reaction technique. Vet Rec 1999;144: 262-264.
26. Slappendel RJ, Ferrer L. Leishmaniasis. In: Green GE, ed. Infectious Diseases of the Dog and Cat. Philadelphia, PA: WB Saunders; 1998:450-458.
27. Faraut-Gambarelli F, Piarroux R, Deniau M, et al. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 1997;41:827-830.
28. Koutinas AF, Kontos V, Kaldrimidou H et al. Canine leihsmaniasis- associated nephropathy: A clinical, clinicopathologic and pathologic study in 14 spontaneous cases with proteinuria. Bull HVMS 1994;45:131-140.
29. Bartges JW, Willis AM, Polzin DJ. Hypertension and renal disease. Vet Clin North Am Small Anim Pract 1996;26:1331-1345.
30. Walker S, Tailor SA, Lee M, et al. Amphotericin B in lipid emulsion, stability, compatibility and in vitro fungal activity. Antimicrob Agents Chemother 1998;42:762-766.
31. Ferrer L, Aisa MJ, Roura X, et al. Serological diagnosis and treatment of canine leishmaniasis. Vet Rec 1995;136:514-516.
32. Steuber S, Moritz A, Schirrmann I, et al. PCR follow-up examination after treatment of canine leishmaniasis (CaL). Tokai J Exp Clin Med 1998;23:285-292.
33. Moritz A, Steuber S, Greiner M. Clinical follow-up examination after treatment of canine leishmaniasis. Tokai J Exp Clin Med 1998; 23:279-283.
34. Mathis A, Deplazes P. PCR and in vitro cultivation for detection of Leishmania spp in diagnostic samples from humans and dogs. J Clin Microbiol 1995;33:1145-1149.
35. Pizzuto M, Piazza M, Senese D, et al. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol 2001;39:357-361.
36. Roura X, Sanchez A, Ferrer L. Diagnosis of canine leishmaniasis by a polymerase chain reaction technique on blood samples. J Vet Intern Med 2000;14:240 (abstract).
37. Reithinger R, Lambson BE, Barker DC, et al. Use of PCR to detect Leishmania (Viannia) spp in dog blood and bone marrow. J Clin Microbiol 2000;38:748-751.
38. Breitschwerdt EB. Visceral leishmaniasis in North America. Proceedings of the 19th ACVIM Forum Denver, 2001:756-757.
39. Solano-Gallego L, Morell P, Arboix M, et al. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J Clin Microbiol 2001;39:560-563.
40. Sharp NJ. Molecular biology of infectious disease. In: Kirk RW, ed. Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders; 2000:835-838.